MondegarAI
MIC Capital Management UK LLP

Q4 2025 · 13F-HR

MIC Capital Management UK LLPholdings as filed

Filed 2026-02-17 · accession 0001889830-26-000001

$441.3M
Reported value
13
Positions
2025-12-31
Period end
View analyzed profile →PRO

The Brief · MIC Capital Management UK LLP · Q4 2025

AI · grounded in 13F

MIC Capital Management UK LLP trimmed its position in Hayward Hldgs Inc HAYW by 15.76%. This was the only reduction in a portfolio consisting of 13 positions. The fund added no new holdings during the period and ended the quarter with $441.3M in total assets under management.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
421298100HAYWHAYWARD HLDGS INC$128.6M29.1%8,322,933CommonSOLE
G5279N105KLARKLARNA GROUP PLC$78.5M17.8%2,714,928CommonSOLE
76155X100RVMDREVOLUTION MEDICINES INC$40.5M9.18%508,569CommonSOLE
75629V104RXRXRECURSION PHARMACEUTICALS IN$39.4M8.94%9,644,032CommonSOLE
22266T109CPNGCOUPANG INC$33.3M7.55%1,412,946CommonSOLE
76131D103QSRRESTAURANT BRANDS INTL INC$26.4M5.97%386,203CommonSOLE
G4124C109GRABGRAB HOLDINGS LIMITED$24.9M5.65%5,000,000CommonSOLE
01609W102BABAALIBABA GROUP HLDG LTD$22.0M4.98%150,000CommonSOLE
30303M102METAMETA PLATFORMS INC$22.0M4.98%33,300CommonSOLE
M7S64H106MNDYMONDAY COM LTD$9.7M2.21%66,000CommonSOLE
640979100NMRANEUMORA THERAPEUTICS INC.$8.0M1.81%4,460,700CommonSOLE
03945R102ACHRARCHER AVIATION INC$5.3M1.19%700,000CommonSOLE
55083R203LYELLYELL IMMUNOPHARMA INC$2.7M0.61%87,028CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.